A new study published in JNCCN found that comprehensive biomarker testing before treatment for advanced lung cancer was associated with patients living longer. Broad-based genomic sequencing helped identify a wider range of tumor biomarkers, guiding targeted treatment and improving survival outcomes.
Researchers developed a blood-based approach to track small-cell lung cancer and understand its biology. The test uses tiny fragments of material released into the bloodstream to identify molecular patterns characteristic of the disease, allowing doctors to assess its progression and respond to therapy. The study offers a promising rou...
A clinical trial has provided valuable data on how tumor plasticity drives treatment resistance in lung cancer patients. Researchers found that combining osimertinib with platinum and etoposide chemotherapy may not prevent transformation, but rather accelerate it.
Researchers have detected signs of neuronal injury in individuals carrying the genetic mutation that causes Huntington's disease, even before symptoms appear. Elevated levels of neurofilament light chain (NfL) were found in individuals classified in the earliest stage of the disease, suggesting different biological conditions may coexist.
Researchers at the University of Cincinnati found a potential biomarker for PTSD susceptibility in female animal models, suggesting a link to stress hormone patterns. The study suggests that a simple stress provocation test could serve as a clinical biomarker for PTSD risk and point toward early interventions. The findings raise the po...
Researchers at Hoag Memorial Hospital Presbyterian discovered a molecular warning signal in the blood that identifies serous tubal intraepithelial carcinoma, an early precancerous stage of ovarian cancer. The breakthrough may enable detection years earlier, transforming ovarian cancer surveillance and prevention.
A study published in Nature Medicine reveals that artificial intelligence can identify associations between human movement patterns and 1,887 health measures spanning 18 body systems. Movement analysis provided independent predictive information beyond traditional health assessments.
The National MS Society is launching a funding opportunity to support innovative screening technologies for early MS detection. The goal is to accelerate progress in identifying individuals at risk of MS, ultimately reducing time to diagnosis and improving long-term outcomes.
Soil tetraether-lipid-based temperature reconstruction in global arid and semi-arid regions has seen advances and challenges. Reliable temperature reconstructions are essential for understanding past climate and testing climate models.
A study of 601 participants found that younger patients with Alzheimer's disease have a higher burden of tau protein at disease onset and faster protein buildup, while older patients display different patterns of disease-linked protein accumulation
A study validated a proteomics workflow that quantified about 50% more proteins in cervicovaginal fluid samples collected daily from the same women. The method allows researchers to track changes in protein levels from one day to the next, opening up new ways to study fertility and biomarkers of clinical interest.
Researchers from Shandong University explore how precisely arranged nanoscale building blocks can produce stronger signals and bring different sensing functions together for disease biomarker detection. Structural design strategies are being used to advance the field, including single-component assembly and multicomponent co-assembly.
A rare case of early-onset Parkinson's disease reveals molecular changes in platelets associated with disease progression. The study identified changes in gene expression in platelets, including those involved in mitochondrial function and protein synthesis, providing insights into molecular processes involved in disease progression.
Researchers have discovered a link between CDK1 protein activity and breast cancer response to CDK4/6 inhibitors. Higher CDK1 activity is associated with more aggressive cancer and poorer outcomes. The study suggests that tracking CDK1 activity could help doctors identify patients most likely to benefit from targeted therapy.
Researchers developed a personalized indicator that analyzes ten blood substances to predict health problems and guide healthy aging in middle age. The tool shows promise in reducing the risk of chronic diseases, with a one-point increase corresponding to a 14-year delay in cardiometabolic disease onset.
A new project aims to use biochemical variables to tailor athletes' rest periods and guide young talent, with a focus on the 2028 and 2032 Paralympic Games. The project seeks to prevent infections and injuries in Paralympic athletes, who are 20 times more likely to contract infections than Olympic athletes.
Researchers found that short, controlled exposure to low-oxygen air reduces cortisol and leptin levels, increases adiponectin, and improves inflammation markers in people with Parkinson's disease. However, more in-depth studies are needed to confirm the effects on sleep and reorganize the sleep-wake cycle.
A study by National Institutes for Quantum Science and Technology researchers found that faster buildup of abnormal tau protein in the brain is linked to faster symptom worsening in progressive supranuclear palsy, a rare neurodegenerative disease. The discovery could help researchers objectively measure disease progression and accelera...
Researchers have developed a blood test that can identify brain injury severity in patients, helping clinicians escalate care. The test uses two proteins, GFAP and UCH-L1, which rise in the bloodstream after injury, and can differentiate between patients with acute brain injury and those with no evidence of pathology.
Researchers at RIKEN have developed a synthetic compound that uses excess carbon monoxide produced by cancer cells to trigger the production of anti-cancer drugs within the cells themselves. The compound selectively targets tumors and avoids harming healthy cells, offering a promising new approach to cancer treatment.
A new study links 12 blood proteins to prostate cancer diagnosed over 15 years after blood sampling, including immune cells and cancer driver genes. The research may help identify men at greater risk of aggressive prostate cancer and inform future studies.
A new study by Klick Labs reveals complex patterns in voice recordings that are associated with Type 2 diabetes. The research used 14,759 voice recordings from 461 adults, analyzing spectrograms and identifying acoustic patterns related to diabetes. The study achieved balanced accuracy of 71.3 percent for women and 72.4 percent for men.
A large-scale study identified distinct antibody patterns up to 10 years before IBD diagnosis, offering insights into future disease course. Researchers found reduced antibody diversity and unique responses in individuals who later developed CD or UC.
A large global study of 15,612 adults found that blood biomarker levels varied across racial and ethnic groups, but the relationship between biomarker levels and brain amyloid was generally consistent. The study's findings support the use of blood-based biomarkers to screen for elevated brain amyloid in preclinical Alzheimer's disease ...
Complement C7 linked to fibrosis severity and liver-related events in MASLD, with elevated levels associated with higher risk of clinical outcomes. Hepatic stellate cells identified as source of C7, supporting its potential as non-invasive biomarker for risk stratification.
Researchers have found that levels of beta-synuclein, a protein related to synaptic function, begin to rise in people with Down syndrome from the third decade of life, decades before symptoms appear. This finding positions beta-synuclein as a promising marker of the earliest synaptic changes associated with Alzheimer's disease.
A significant proportion of patients with HER2-positive, ER-negative breast cancer can achieve a pathologic complete response after 12 weeks of THP chemotherapy. The trial identified ER-negative or low ER-expressing tumors, low or no progesterone receptor expression, HER2 IHC 3+ tumors, and weekly paclitaxel treatment as key predictors...
USC researchers are conducting a clinical trial to test whether mindfulness training can enhance the benefits of psilocybin therapy for depression. The study will compare psilocybin therapy with and without an eight-week mindfulness training program, aiming to investigate the synergistic effect of combining the two treatments.
Researchers identify key role of spatial niche in early gastric cancer initiation and progression, highlighting inflammation-associated spatial niche as fundamental regulatory unit. Targeting inflammation-associated spatial niches may enable earlier and more precise therapeutic strategies.
The study found substantial international variability in laboratory testing for bone and mineral metabolism, limiting data sharing and clinical impact. The survey highlights the need for greater consistency in BSI testing to improve clinical utility and patient care.
A blood test that compares two molecules in the blood can accurately distinguish between bacterial and viral infections in newborn babies with fever. The test showed a high sensitivity and specificity, and could potentially improve treatment and reduce unnecessary antibiotic use.
Researchers have developed a laser-powered technology that accelerates antibody-antigen interactions to detect tiny amounts of a colorectal cancer biomarker within minutes. This technology has the potential to improve cancer diagnosis by increasing detection sensitivity and speed.
A new study identified dozens of blood proteins that change during treatment with lecanemab, an anti-amyloid drug, which may help monitor treatment effects and predict disease progression. The study found changes in proteins related to inflammation and amyloid clearance, which could inform clinical decision-making and potentially lead ...
A new diagnostic test for Alzheimer's disease is being developed using blood-based diagnostics, which could provide a more accurate prognosis and treatment options. The test, led by Lund University, aims to improve early diagnosis and treatment of the disease.
Researchers found similar diarrhea outcomes among patients with low and normal fecal elastase levels, suggesting stool dilution is a possible cause. Fecal fat testing is recommended before enzyme therapy to confirm exocrine pancreatic insufficiency.
Researchers identified a link between B cell activity and immunotherapy-related colitis, a common side effect of cancer treatments. Higher B cell levels before treatment were associated with increased colitis risk, and depleting B cells reduced colitis severity.
A new blood test, PANXEON, detects stage 1 and 2 pancreatic cancer with high sensitivity and low false-positive rates, identifying high-grade dysplasia with 64% accuracy. The test could enable early intervention and improve treatment options for patients with inherited risk or family history of pancreatic cancer.
A five-year project led by UC Riverside researcher Erica Heinrich seeks to improve respiratory care for patients with conditions like COPD and those on mechanical ventilation. The study aims to develop a machine-learning algorithm that can predict respiratory comfort more accurately than physicians' estimates.
The SUNY Technology Accelerator Fund is providing grants to support research in AI, energy-efficient semiconductors, and non-invasive monitoring. Five campuses will receive funding for projects that could improve cancer diagnostics, circadian rhythm disorders, and burn diagnostics.
A team at the Hôpital ophtalmique Jules-Gonin recorded the retina's spontaneous electrical activity in patients with retinitis pigmentosa, revealing abnormal rhythms. The findings suggest that the retina is not as silent as previously thought and that measuring its activity could help guide sight-restoring therapies. The study's result...
Researchers developed an automated method to convert standard eye scans into an objective cataract biomarker. The method, tested on 1906 eyes, demonstrated exceptional diagnostic discrimination and strong correlation with a standard cataract grading system.
A new review in Science Bulletin outlines how multimodal AI can integrate molecular, cellular, and clinical data to refine treatment choices and predict side effects. The approach aims to address challenges in cancer treatment, including primary resistance and immune-related adverse events.
Researchers found that rituximab treatment increases mitochondrial energy production and reduces cell stress in T cells, leading to improved response rates in patients with nephrotic syndrome. This discovery could help predict patient response to treatment and identify suitable candidates for early remission.
A new platform enables non-invasive tracking of early microvascular disease changes using ultrasound localization microscopy. The U-VBA framework standardizes analysis of tiny blood vessels, capturing structural and hemodynamic properties, and shows high reproducibility and accuracy in classification of cervical lymph-node conditions.
Researchers discovered that cancer cells with RET mutations produce higher levels of the OPG protein, which disrupts bone renewal and blocks destruction, favoring bone accumulation. Measuring OPG levels via blood tests could identify and monitor patients with aggressive disease.
Researchers will develop a molecular diagnostic test that quantifies small RNA species to detect fetal oxygen deprivation during labor. The technology aims to provide clinically relevant values for stratifying the risk of babies during labor.
A new study reveals striking biological similarities between five major illnesses, including long Covid and PTSD, suggesting common underlying mechanisms. Chronic fatigue syndrome, rheumatoid arthritis, and multiple sclerosis may be driven by shared regulatory networks in immune and metabolic systems.
Prostate cancer affects 1 in 8 men, with 60% diagnosed in men 65 and older. Clinical trials like Alliance's help improve early detection and treatment, reducing mortality rates by half since 1993. These trials also explore new treatments and survivorship strategies.
A new study by UTHealth Houston found measurable biological changes in firefighters' blood and urine 24 hours after fighting a fire, which may help identify early cancer risk. The study identified 75 significantly altered proteins in urine and 10 in blood serum, with several linked to cancer-related pathways.
Researchers developed a first-in-class therapy targeting MYC, a protein involved in 70% of cancers, by disrupting its relationship with GSPT1. This approach showed strong anti-cancer activity in multiple types of blood cancers, including treatment-resistant models.
Researchers at the University of Toledo have developed a rapid blood screening method to detect elevated bile acids, an early but overlooked marker of liver disease. The test, which has been patented, can accurately identify individuals with high bile acids and has the potential to save lives by catching liver disease early.
Researchers from Hebei Medical University review current evidence on prolonged disorders of consciousness (pDOC) management. They propose a brain communication network model to explain how brain injury leads to long-term unconsciousness, identifying key brain electrical signaling activity measures for diagnosis and treatment.
The PolyU developed AI Virtual Patient Simulation System combines multimodal data from genomic, medical imaging and clinical records to create a digital twin model tracking real-time changes in a patient's condition. It predicts the effectiveness of different cancer treatment options and supports personalized medical solutions.
Researchers developed an AI model that analyzes routine whole histopathology images to predict cancer subtype, genetic mutations, and survival outcomes across 32 solid cancers. The model achieved a strong predictive accuracy score for TP53 mutation detection and demonstrated the ability to infer RNA expression levels and tumor taxonomy.
SourceElsevier·JournalAmerican Journal Of Pathology·TypeComputational simulation/modeling·DateAug 13, 2026
Researchers identify AGR2 as a prognostic marker for NF-PanNETs, while FOXM1 is found to promote malignancy and proliferation. AGR2-high cells exhibit malignant features, including increased proliferative activity and metastasis-like signatures.
Researchers from USC-led study found that different epigenetic clocks capture distinct aspects of cellular aging, while introducing new gene-expression based clocks with stronger predictive power. These tools can better predict age-related disease and mortality by examining DNA methylation patterns and gene expression.
Pyrogallol's toxicity in aquatic organisms has been linked to oxidative stress and damage across multiple biological systems. The analysis identifies the need for broader environmental surveillance, long-term ecological studies, and improved exposure assessment to determine its effects on human health.
Researchers identified two immune cell populations present in both initial and recurrent arthritis flares, suggesting an immune-memory disease. These cells may serve as biomarkers for high-risk patients or to guide targeted therapies to reduce side effects.
Researchers developed a method to predict how different types of breast cancer will respond to treatment using lab-grown mini tumors. The organoids mimicked a tumor's response to treatment and identified candidate combination therapies for cancers that don't respond to standard treatment.
Researchers developed a multiprotein approach to predict advanced tau pathology among amyloid-positive individuals, outperforming p-tau217 alone. This study suggests a scalable alternative to tau PET staging for clinical or research settings.